Michelle D. Hackshaw

Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma

Robert J. Motzer, Thomas E. Hutson, David Cella et al. · New England Journal of Medicine · 2013 · 1.9K citations · Full text

Multilevel Bayesian Models for Survival Times and Longitudinal Patient-Reported Outcomes With Many Zeros

Laura A. Hatfield, Mark E. Boye, Michelle D. Hackshaw et al. · Journal of the American Statistical Association · 2012 · 45 citations

Cost-Effectiveness of Pazopanib Versus Sunitinib for Renal Cancer in the United States

Thomas E. Delea, Jordan Amdahl, Jose Diaz et al. · Journal of Managed Care & Specialty Pharmacy · 2015 · 42 citations · Full text

Quality‐adjusted time without symptoms or toxicity analysis of pazopanib versus sunitinib in patients with renal cell carcinoma

Jennifer L. Beaumont, John M. Salsman, Jose Diaz et al. · Cancer · 2016 · 42 citations · Full text

Health Care Costs Among Renal Cancer Patients Using Pazopanib and Sunitinib

Ryan N. Hansen, Michelle D. Hackshaw, Saurabh Nagar et al. · Journal of Managed Care & Specialty Pharmacy · 2015 · 33 citations · Full text